Cite

HARVARD Citation

    Nanfuka, M. et al. (2021). Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda. Medicine. 100 (19), p. . [Online]. 
  
Back to record